UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):

 

April 30, 2008

 

APOGEE TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-10456

 

04-3005815

(State or other jurisdiction of
incorporation or organization)

 

(Commission
File Number)

 

(IRS employer
identification no.)

 

129 Morgan Drive

Norwood, Massachusetts 02062

(781) 551-9450

(Address, including zip code, and telephone number, including area code,

of registrant’s principal executive offices)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

 

ITEM 8.01 OTHER EVENTS.

 

Apogee Technology, Inc. (the “Company”), issued a press release on April 30, 2008 regarding the completion of in vivo proof-of-concept studies and the filing of a new U.S. patent application relating to its intradermal drug delivery technology.

 

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference in this Item 8.01.

 

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

 

(c) Exhibits

 

99.1

 

Press release dated April 30, 2008.

 

 

 

 

 

2


 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

APOGEE TECHNOLOGY, INC.

 

 

 

 

 

 

Dated: April 30, 2008

By:

/s/ Herbert M. Stein

 

 

Herbert M. Stein

 

 

President, Chief Executive Officer and

 

 

Chairman of the Board

 

 

 

 

 

 

3


 

 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press release dated April 30, 2008.

 

 

 

 

 

 

 

 

 

4